534 related articles for article (PubMed ID: 16789009)
1. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
3. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
Tan EL; Peh SC; Sam CK
J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
[TBL] [Abstract][Full Text] [Related]
4. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals.
Shu CH; Tu TY
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):288-93. PubMed ID: 10820907
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
7. [Detection of EBV by PCR in fresh and paraffin embedded samples of cavum tumour].
Charef S; Jrad BB; Mahfouth W; Zakhama A; Kassab A; Driss N; Chouchane L
Arch Inst Pasteur Tunis; 2006; 83(1-4):41-7. PubMed ID: 19388596
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF
Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
[TBL] [Abstract][Full Text] [Related]
10. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China.
Chen JN; Ding YG; Feng ZY; Li HG; He D; Du H; Wu B; Shao CK
J Med Virol; 2010 Apr; 82(4):658-67. PubMed ID: 20166192
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
12. Infection frequency of Epstein-Barr virus in subgingival samples from patients with different periodontal status and its correlation with clinical parameters.
Wu YM; Yan J; Chen LL; Sun WL; Gu ZY
J Zhejiang Univ Sci B; 2006 Nov; 7(11):876-83. PubMed ID: 17048301
[TBL] [Abstract][Full Text] [Related]
13. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
[TBL] [Abstract][Full Text] [Related]
14. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
16. New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China.
Wang Y; Zhang X; Chao Y; Jia Y; Xing X; Luo B
J Med Virol; 2010 May; 82(5):829-36. PubMed ID: 20336720
[TBL] [Abstract][Full Text] [Related]
17. Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.
Zeng MS; Li DJ; Liu QL; Song LB; Li MZ; Zhang RH; Yu XJ; Wang HM; Ernberg I; Zeng YX
J Virol; 2005 Dec; 79(24):15323-30. PubMed ID: 16306603
[TBL] [Abstract][Full Text] [Related]
18. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative analysis of Epstein-Barr virus DNA in plasma and peripheral blood cells in patients with nasopharyngeal carcinoma].
Zhang Y; Gao HY; Feng HX; Deng L; Huang MY; Hu B; Cheng G; Wu QL; Cui NJ; Shao JY
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):982-6. PubMed ID: 15312530
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
Mutirangura A; Pornthanakasem W; Theamboonlers A; Sriuranpong V; Lertsanguansinchi P; Yenrudi S; Voravud N; Supiyaphun P; Poovorawan Y
Clin Cancer Res; 1998 Mar; 4(3):665-9. PubMed ID: 9533535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]